SAGE Therapeutics Inc (NASDAQ: SAGE): Solid Pipeline, Impressive Price Targets

Small-cap biotechnology company SAGE Therapeutics Inc (NASDAQ: SAGE), which suffered a debacle in September 2017 in the late stage trials of its brexanolone (SAGE-547) treatment for experimental super-refractory status epilepticus (SRSE),...

Could the “Better Botox” From Revance Therapeutics Inc (NASDAQ: RVNC) Be Allergan’s Nemesis?

Shares in already beleaguered Allergan plc (NYSE: AGN) were dealt a body blow Tuesday after Revance Therapeutics Inc (NASDAQ: RVNC) announced favourable results from a pair of phase 3 clinical trials...

PhaseRx Inc (NASDAQ: PZRX) Has Good News…But Does It Have Cash and Time?

Shares in PhaseRx Inc (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver diseases in children, have popped 76% in the last two sessions. The catalyst for the rally...

Abeona Therapeutics: Don’t Be Afraid to Buy the Hype

Over the last couple of months, Abeona Therapeutics stock has ticked up, up, and up. Many investors are questioning whether or not they should actually buy the hype of this stock,...

Ra Pharmaceuticals Plummets on Phase II Initial Clinical Trial Data, What You Need to...

Ra Pharmaceuticals Inc (NASDAQ: RARX) shares ended down just over 20% today. The stock’s plummet was primarily attributed to its announcement of initial data from its Phase II clinical program for...
Celsion

Celsion Shares Up Over 7% After Cancellation of Registered Direct Offering

Celsion Corporation (NASDAQ: CLSN) shares were up over 7% today, after the company announced that it cancelled its registered direct offering of common stock. That said, this action would not dilute...

Vanda Pharmaceuticals Ended Up Over 8%, and Here’s What You Need Know

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) shares were up over 8% today, after an investment company filed an SEC Schedule 13G. Additionally, there were other insiders who filed SEC Form 4s. That...
Rigel

Here’s What You Need to Know About Rigel’s Strong Performance Today…

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares were up over 10% on the day, after the company announced that the U.S. Food and Drug Administration (FDA) accepted the company’s New Drug Application...

Celsion Withdrawing From Stock Offering and Shares Rise Over 50%, Here’s What You Need...

Celsion Corporation (NASDAQ:CLSN) shares were up over 50% today, after the company filed a request to withdraw registration statement on Form S-1. That said, this was the primary catalyst that sent...

Epizyme Had A Volatile Session, and Here’s What You Need to Know…

Epizyme Inc (NASDAQ: EPZM) shares ended up over 10% today, but it was a volatile session for the clinical-stage biopharmaceutical company. The company sold off shortly after the open, after it...